AIMCA
ARCT icon

Alberta Investment Management Corp (AIMCo)’s Arcturus Therapeutics ARCT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,602
Closed -$275K – 1053
2023
Q2 		$275K Buy
+9,602
New +$261K ﹤0.01% 1072

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ARCT Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Arcturus Therapeutics (ARCT) in Q3 2023, closing a stake of 9,602 shares — an estimated $275K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ARCT in Q2 2023 and held it in 1 quarter. The position peaked at $275K in Q2 2023. 145 funds tracked by Wall St. Rank hold ARCT as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Arcturus Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 9,602 Arcturus Therapeutics shares in Q3 2023, an estimated $275K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Arcturus Therapeutics in Q2 2023 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Arcturus Therapeutics position peaked at $275K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.